Prescription Drug Labeling and Price Advertising

Prescription Drug Labeling and Price Advertising
Author :
Publisher :
Total Pages : 420
Release :
ISBN-10 : UIUC:30112067924305
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Prescription Drug Labeling and Price Advertising by : United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance

Download or read book Prescription Drug Labeling and Price Advertising written by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance and published by . This book was released on 1976 with total page 420 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Prescription Drug Labeling and Price Advertising Related Books

Prescription Drug Labeling and Price Advertising
Language: en
Pages: 420
Authors: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance
Categories: Advertising
Type: BOOK - Published: 1976 - Publisher:

DOWNLOAD EBOOK

Prescription Drug Labeling and Price Advertising
Language: en
Pages:
Authors:
Categories:
Type: BOOK - Published: 1977 - Publisher:

DOWNLOAD EBOOK

Prescription Drug Labeling and Price Advertising
Language: en
Pages: 410
Authors: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Consumer Protection and Finance
Categories: Drugs
Type: BOOK - Published: 1976 - Publisher:

DOWNLOAD EBOOK

Prescription Drug Labeling and Price Advertising - Hearings, 94Th Congress, 2Nd Session, 1976
Language: en
Pages: 200
Authors: United States. Congress. House. Committee on Interstate and Foreign Commerce
Categories:
Type: BOOK - Published: 1977 - Publisher:

DOWNLOAD EBOOK

Direct-to-Consumer Advertising of Prescription Drugs
Language: en
Pages: 0
Authors:
Categories:
Type: BOOK - Published: 2009 - Publisher:

DOWNLOAD EBOOK

So far, Members of the 111th Congress have indicated interest in DTC advertising in the context of drug safety, tax treatment of advertising expenses, risk comm